Fine Mapping of the Darier's Disease Locus on Chromosome 12q  by Richard, Gabriele et al.
Fine Mapping of the Darier's Disease Locus on 
Chrotnosotne 12q 
Gabriele Richard, Andrea R. Wright, Sheryl Harris, Sharon Z. Doyle, Bernhard Korge, Cinzia Mazzanti,* 
Toshihiro Tanaka, t Wolfgang Harth,* O. Wesley McBride,§ John G. Compton, Sherri]. Bale, * 
John]. DiGiovanna~ 
Genetic Studies Section, Laboratory of Skin Biology, NIAMS, National Institutes of Health, Bethesda, Maryland, U.S.A.; 'Istituto 
Dermopatico dell'Immacolata, Rome, Italy; tDepartment of Dermatology, Kyoto Universiry, Kyoto, Japan; :j:Hautklinik, Erfurt, 
Germany; §Laboratory of Biochemistry, DCBDC, and ~Dermatology Branch, National Cancer Institute, National Institutes of Health, 
Bethesda, Maryland, U.S.A. 
Darier's disease (DD) is an autosomal dominant geno-
dermatosis characterized by epidermal acantholysis 
and dyskeratosis. We have performed genetic linkage 
studies in 10 families with DD (34 affected) byanalyz-
ing 14 polymorphic micro satellite markers. Our re-
sults confirm recent reports mapping the DD gene to 
chromosome 12q23-q24.1. Haplotype analysis of re-
combinant chromosomes in our families, along with 
previously reported data, narrow the location of the 
D arier's Disease (DD) is an autosomal dominant gen-odermatosis, characterized clinically by brown, hy-perkeratotic, follicular papules and plaques, often in a seborrheic distribution. Papules may occur on the hands and feet, and pits on the palms and soles. 
Mucous membranes and nails may be involved. The disease usually 
presents in childhood and clinical signs may be visible as early as 3 
years of age [1). Although involvement is often mild, severely af-
fected patients can have extensive, malodorous, infected lesions 
leading to scarring and disfigurement. 
The histologic features of DD include focal acantholysis and 
dyskeratosis [2). Based on ultrastructural and immuno-f1uorescence 
observations, it has been suggested that the pathogenesis of the 
disease involves an abnormality of cell adhesion resulting from 
disturbed desmosome-keratin intermediate filament interactions 
[3-6]. 
Linkage of DD to the chromosomal region 12q23-24.1 was ini-
tially reported by Craddock et af [7) and Bashir et af [8). Subse-
quently, the DD gene was further localized to a 12 cM interval 
flanked by the loci D12S78 and D12S79 [9). 
We have studied 10 families with DD using 14 markers and 
confirm linkage to chromosome 12q21.3-q24.1. Examination of 
recombinations identified in our patients, taken together with a 
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DD gene to a 5 cM interval flanked by the loci D12S354 
and D12S84/D12S105. This localization allowed ex-
clusion of two known genes, PLA2A and P AH, as can-
didate loci for DD. Three other gene loci (PPP1C, 
PMCH, PMCA1), mapping in 12q21-q24, remain po-
tential candidates. Keywords: genodermatosis/keratosis 
follicularis/epidermis/linkage. ] Invest DermatoI103:665-
668,1994 
recent report by Strachan et ai, .. enabled us to refine mapping of the 
DD locus to a 5 cM interval between the markers D12S354 and 
D12S84/D12S105. 
MATERIALS AND METHODS 
f 
Clinical Evaluation Our sample included 34 affected and 39 unaffected 
individuals from 10 multi-generation DD families (Fig 1). One family each 
was ItaIian, Japanese, and German. One US family was Mexican-American 
and the remainder were Caucasian, primarily of European ancestry. The 
diagnosis of DD was established by derma to logic examination and was 
confirmed by skin biopsy in at least one affected member from nine of the 10 
families. 
DNA Analysis Genomic DNA was isolated by standard methods [10]. 
DNA was amplified using polymerase chain reaction methodology. Reac-
tions were performed in a volume of 20 III containing 100 ng genomic 
DNA, 150 nM of each primer, 200 IlM each of dA TP, dGTP, and dTTP, 25 
f.lM dCTP, 0.066 f.ll opzP-dCTP (3000 Ci/mmol), 10 mM Tris-HCl (PH 
8.3), 50 mM KCl, 1.5 mM MgClz, and 0.5 U of Taq polymerase 
(Boehringer-Mannheim), overlaid by mineral oil. After initial denaturation 
at 94°C for 2 min, cycle conditions were 94°C for 1 min, 55°C for 1 min, 
and 72°C for 1.5 min (35 cycles), followed by a 10-min final extension step 
at 72°C. The amplified DNA was separated on 6% sequencing gels (6 M 
urea) under standard electrophoretic conditions. 
Microsatellite marker loci analyzed included D12S95, D12S377, 
D12S58, GATA15A03, D12S78, D12S84, D12S105, D12S79, D12S86, 
GATA4H01, D12S378 [11-13] and the genes for insulin-like growth fac-
tor 1 (IGF1) [14], phenylalanine hydroxylase (PAH) [15] and pancreatic 
phospholipase A-2 (PLA2A) [16]. The order and sex-averaged distances 
shown in Fig 2 were derived from two sources [12,13]. 
Linkage Analysis All linkage analyses were performed using the LiNK-
AGE package of programs. Lod scores and recombination fractions were 
•• Strachan T, Munro CS, Carter S, Mason S, Stevenson A, Bashir R, 
Bryce S, Healy E, Rees JL: More precise localization of the Darier's disease 
gene on chromosome 12q (abstr).] bluest Dertnatoll02:540, 1994. 
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Figure 1. Pedigrees ofl0 families with DD used for linkage analysis. 
Solid symbols indicate affected individuals, open symbols, unaffected individu-
als. Generation numbers are written in Roman numerals and individual 
identification numbers are in Arabic numerals. 
calculated assuming a disease allele frequency of 1 :100,000. Because DD has 
age-dependent penetrance, the disease was modeled to account for the prob-
ability that an individual with the disease allele would express the clinical 
signs as a function of age. Therefore, five liability classes were defined [1,17] . 
Marker allele frequencies were established from a series of unaffected control 
persons or published sources. 
RESULTS 
Pair-Wise Linka~e Analyses of DD The pair-wise lod scores 
for 11 microsatellite markers on chromosome 12q are shown in 
Table I. Eight marker loci gave significantly positive lod scores that 
maximized at e = zero, confirming linkage ofDD to chromosome 
12q23-q24.1. Recombination was observed with markers flanking 
this interval, D12S377 and D12S86 (Table I), and D12S95, 
GATA4HOl and D12S378 (data not shown). 
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Figure 2. Map of markers on chromosome 12q used for linkage 
analysis. Approximate location along chromosome 12 is shown on the 
ideogram. Order and distances for the markers were derived from maps 
r
ublished by the Cooperative Human Linkage Centre and Genethon 
12,13]. 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
region and were analyzed using known polymorphisms [14-16]. 
Recombination between PLA2A and DD excluded PLA2A from 
further consideration as a candidate for the disease. However, PAH 
and IGFI could not be excluded by pair-wise linkage analysis. 
Additional Marker and Haplotype Analysis To refine the lo-
cation of the DD locus, recombinant chromosomes were identified 
by haplotype analysis and additional markers between D12S84 and 
D12S86 were analyzed, including D12S354, D12S369, D12S366, 
and D12S349 [12]. Haplotypes were deduced with the marker order 
presented in Fig 2 and are shown for two families in Fig 3. 
Informative recombinations were observed in affected individu-
als in three families (D002, D003, and D006). In individual D002-
III-2, recombination occurred between D12S369 and D12S349 
(D12S366 was uninformative), placing the DD locus proximal 
(towards the centromere) to D12S349 (Fig 3). In family D003 a 
single recombination between D12S366 and D12S369 was ob-
served in individual IV -1. Similarly, recombination in D006-III-4 
between the disease locus and D12S366 localizes the disease proxi-
mal to D12S366 (Fig 3). 
Several clinically unaffected individuals from four families (D25, 
d2995, D003, and D006) inherited recombinant chromosomes. In 
family d25, an unaffected 23-year-old man (III-2) retained from 
his affected parent the disease-carrying chromosome at D12S79 and 
distal (towards the telomere). Another unaffected 16-year-old man 
(d2995-III-2) inherited his father's disease chromosome at D12S79 
and distal (D12S354 was uninformative in this individual) . These 
results place the disease locus proximal to D12S79. Moreover, an 
unaffected 12-year-old girl (IV-5) in family D003 retained 
D12S354 as well as D12S79 and the more distal marker alleles from 
the parental disease chromosome. This identifies D12S354 as the 
distal flanking marker for the interval containing the DD locus. 
Finally, one reported unaffected individual (D006-III-l) , 25 years 
old, inherited the disease chromosome proximal to D12S78, in-
cluding the PAH locus (Fig 3). This data establishes PAH as the 
proximal flanking marker and excludes it as the disease gene. 
DISCUSSION 
Our data confirm the localization of the DD gene to chromosome 
12q23-q24.1. All families studied to date are consistent with this 
location [7 - 9], tt strongly suggesting genetic homogeneity in DD. 
Haplotype analysis in families with recombinant individuals al-
lowed us to refine the DD gene location. Data in recombinant 
affected individuals (i.e., D006-1II-4, Fig 3) places the DD locus 
proximal to D12S366. Information from unaffected recombinant 
individuals narrows the interval further. A 23-year-old man (d25-
III-2) showed no evidence of DD by careful clinical examination. 
Other affected family members reported disease onset between the 
ages of 7 and 10 years. H aplotype analysis revealed that d25-III-2 
retained the disease chromosome at D12S79 and distal, and places 
the DD locus proximal to D12S79. A similar conclusion can be 
drawn from analysis of family d2995, where individual III-2 was 
unaffected on our dermatologic examination at age 16 although 
other affected members in this family had severe involvement with 
disease onset between the ages of 5 and 7 years. It is therefore 
unlikely that this individual carries the DD gene. The recombina-
tion events with D12S79 were not evident from the pair-wise anal-
yses (Table I) because obligate recombination events can be ob-
served only in affected individuals under a reduced penetrance 
model. Localization of DD proximal to D12S79 is consistent with 
the findings of Parfitt et af [9], who identified D12S79 as the distal 
flanking marker based on recombinations in 2 families. Recombina-
tion in another unaffected individual in our sample further re-
stricted the distal boundary. Careful dermatologic examination of 
children in DD families for subtle signs of disease can allow diagno-
sis at a young age, years before the development of symptoms lead-
ing to physician consultation for treatment. Individual D003-IV-5 
tt Wakem P, Ikeda S, Haake A, Ewing N, Polakowska R, Sarret Y, 
Trattner A, Shohat B, Schroeder OW, Epstein EH Jr, Goldsmith LA: Local-
ization of the Darier's disease gene (abstr). ] Iflvest Derlllatoll02:541, 1994. 
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Table I. Pair-Wise lod Scores for Chromosome 12q Markers in 10 Families with Darier's Disease 
e (Recombination frequency) 
Locus 0.00 0.001 0.05 
D12S377 -7.19 -1.14 1.24 
IGFl 4.36 4.36 3.96 
GATA15A03 7.01 7.00 6.30 
D12S58 6.70 6.69 6.20 
PAH 8.44 8.42 7.58 
D12S78 6.98 6.97 6.28 
D12S84 7.21 7.20 6.56 
D12S105 6.49 6.48 5.79 
D12S79 6.36 6.35 5.75 
D12S86 -14.06 -4.76 0.19 
PLA2A -9.61 -5.70 -0.72 
• Z and e are maximum likelihood estimates of lod score and recombination fraction. 
had no evidence of DD on examination at age 12 years, whereas 
four affected members of this family developed disease between the 
ages of 6 and 9 years . Therefore, the probability that D003-IV-5 
carries the disease gene is remote. Because this individual inherited 
the disease chromosome at D12S354 and distal, we can identify 
D12S354 as the distal flanking marker. 
Finally, haplotype analysis ofD006-III-l, a 25-year- old individ-
ual, defines PAH as the proximal boundary in our study (Fig 3). 
However, recombinations were recently reported with both 
markers D12S84 and D12S105.** These data, together with our 
results, narrow the interval containing the DD locus to a 5 cM 
interval between D12S354 and D12S84/D12S105 . 
Neuropsychiatric disorders have been observed in patients with 
DD [17 - 19] and recently Craddock et al [20] reported co-segrega-
tion ofDD and major affective disorder inone large family . We did 
not systematically collect information regarding neuropsychiatric 
disorders in our families. However, two affected individuals from 
different families required psychiatric hospitalization, one for major 
affective disorder and the other for mental retardation. In a third 
family, one patient with DD committed suicide. Because neuropsy-
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Figure 3. Pedigrees of two families with DD showing disease status 
and genotypes for 11 markers on chromosome 12. Ages of individuaIs 
in the youngest generation are in parentheses. The haplotype carrying the 
DD gene in each family is shaded in gray. Horizorltal bars indicate recombi-
nation between adjacent markers in the parental chromosome. 
•• Strachan T, Munro CS, Carter S, Mason S, Stevenson A, Bashir R, 
Bryce S, Healy E, Rees JL: More precise localization of the Darier's disease 
gene on chromosome 12q (abstr).J I" vest DermaloI102:S40. 1994. 
0.10 0.20 0.30 0.40 za ea 
1.58 1.43 0.92 0.35 1.61 0.12 
3.54 2.63 1.69 0.78 4.36 0.00 
5.56 4.01 2.44 1.00 7.01 0.00 
5.56 4.09 2.46 0.94 6.70 0.00 
6.68 4.81 2.87 1.11 8.44 0.00 
5.55 3.99 2.39 0.92 6.98 0.00 
5.82 4.19 2.46 0.90 7.21 0.00 
5.08 3.58 2.09 0.80 6.49 0.00 
5.07 3.58 2.03 0.67 6.36 0.00 
0.81 0.95 0.61 0.20 0.98 0.16 
0.00 0.41 0.34 0.14 0.41 0.22 
chiatric disorders occur consistently in some DD families but spo-
radically in others, the relationship between neuropsychiatric disor-
ders and DD remains to be resolved. 
The nature of the D D gene remains unknown. Several genes with 
known polymorphism have been assigned to chromosome 12q22-
q24 and were tested as candidates for DD in this study. We could 
exclude PLA2A because of recombinations with the DD locus. 
PAH and IGF1 lie outside the region containing the DD locus 
defined by Parfitt et al [9] . Our results of haplotype analysis support 
this exclusion. because an unaffected individual (D006-I1I-2) inher-
ited the PAH, IGFI. and other proximal marker alleles from the 
disease chromosome of the affected parent. However. because the 
precise location of IGF1 is not known. it cannot be conclusively 
eliminated. 
Several other genes with potential involvement in DD have been 
mapped to 12q21-q24. including protein phosphatase 1 (PPPIC) 
[21]. pro-melanin-concentrating hormone (PMCH) [22]. and 
plasma membrane Ca++- ATPase 1 (PMCAl) [23] . The gene 
PPP1 C encodes one of the three known catalytic subunits of protein 
phosphatase 1. This enzyme. implicated in protein phosphoryl-
ation. is involved in cell division, glycogen metabolism, and protein 
synthesis [24] . Changes in the activity of PPPI C could hypotheti-
cally interfere with the function of desmosomal and cell adhesion 
proteins, due to changes in their state of phosphorylation [25] . 
PMCH encodes the neuropeptide pro-melanin-concentrating 
hormone. It has been proposed as an effector in a broad array of 
neuronal functions [22J. The presence or expression of PMCH in 
the epidermis is unknown. 
Plasma membrane Ca++-ATPase 1 (PMCAl) is one of four 
known members of a multi gene family of ion-motive ATPases that 
are crucial for intracellular calcium homeostasis [23] . Calcium is 
known to play an important role in epidermal differentiation, and 
disturbed intracellular calcium regulation could interfere with ter-
minal differentiation, resulting in abnormal cell adhesion and pre-
mature cornification of keratinocytes. Further investigations of 
each of these genes, including the identification of useful polymor-
phisms for linkage mapping, will be necessary to test their potential 
role in the pathogenesis of DD . 
We have refined the interval containing the DD gene. Further 
haplotype analysis with additional markers in this interval and 
physical mapping techniques can be used to identify the DD gene. 
This will lead to a better understanding of disease pathogenesis and 
the potential for developing new approaches to therapy. 
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ANNOUNCEMENT 
A symposium sponsored by the Deutsche Forschungsgemeinschaft and the Alexander-von-
Humboldt-Foundation, "Molecular Mechanisms in Dermal-Epidermal Interactions," will be 
held in Kloster Irsee/Germany (approximately 120 km west of Munich), March 10-13, 1995. 
It is being organized by E. Christophers, Kiel; T. Krieg, Cologne; and D. Roop, Houston. 
The aim of this symposium is to discuss the role of cell-cell and cell-matrix connection for 
cellular differentiation, embryonic development, wound healing, and inborn as well as acquired 
diseases of the skin. The meeting will include plenary lectures, poster sessions, and workshops. 
Participants will be limited to 80 to allow a detailed and profound discussion. 
Application forms for participation should be sent to Prof. T . Krieg, Department of Derma-
tology, 50924 Koln, FRG. 
